Bortezomib-containing multimodality treatment for antibody-mediated rejection with anti-HLA and anti-AT1R antibodies after kidney transplantation / S. Iesari, Q. Lai, E. Favi, F. Pisani. - In: YONSEI MEDICAL JOURNAL. - ISSN 0513-5796. - 58:3(2017), pp. 679-681. [10.3349/ymj.2017.58.3.679]
Bortezomib-containing multimodality treatment for antibody-mediated rejection with anti-HLA and anti-AT1R antibodies after kidney transplantation
E. Favi;
2017
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ymj-58-679.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
555.89 kB
Formato
Adobe PDF
|
555.89 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
